If you do not see this message clearly, please
click here
|
 |
DEAR_USER
A friendly welcome to our April 2017 Newsletter.
Our April issue is entirely dedicated to endoscopic thyroid surgery, shedding light on a novel pioneering technique, PerOral Endoscopic Thyroidectomy (POET), based on the principles of natural orifice transluminal surgery (NOTES) as it allows for a truly scar-free surgery with minimal dissection. This technique was originally demonstrated by Dr. Angkoon Anuwong, MD (Bangkok, Thailand).
To capture your interest in general laparoscopic surgery, this month also features a brand-new state-of-the-art presentation on treatment modalities for choledocholithiasis.
The objective of this state-of-the-art is to identify different clinical presentations of common bile duct stones (CBDS), to illustrate the different treatment modalities and provide indications to fine-tune the best therapeutic strategy depending on available means and resources.
We would like to remind you that the WeBSurg Hall of Fame is more current than ever. It has been running on an ongoing basis for several months and it is still on.
The objective is to highlight the best HD video contributor who has covered original comprehensive and academic educational topics in the field of minimally invasive surgery.
Our May issue will feature laparoscopic pancreatic surgery.
Stay tuned!
Thank you once again for your concern and interest in our expanding WeBSurg community.
Your feedback is always appreciated.
Please contact us here.
|
Yours faithfully,
Prof. Jacques Marescaux,
MD, FACS, Hon FRCS, Hon JSES, Hon FASA
President of IRCAD
WeBSurg Editor-in-Chief
|
|
 |
THIS MONTH'S FOCUS ON
ENDOSCOPIC THYROID SURGERY
Discover a novel pioneering technique, PerOral Endoscopic Thyroidectomy (POET), based on the principles of natural orifice transluminal surgery (NOTES) as it allows for a truly scar-free surgery with minimal dissection. This technique was originally described by Dr. Angkoon Anuwong, MD (Bangkok, Thailand).
|
|
 |
STATE-OF-THE-ART:
TREATMENT MODALITIES FOR CHOLEDOCHOLITHIASIS
Educational objectives:
- to identify different clinical presentations of common bile duct stones (CBDS)
- to illustrate the different treatment modalities
- to provide indications to fine-tune the best therapeutic strategy depending on available means and resources.
|
|
DOWNLOADABLE EDUCATIONAL
STATE-OF-THE-ART PACKAGES
Leverage your skills with a series of educational videos, which will lead the way to your learning objectives.
Make the most of our experts' state-of-the-art presentations on therapeutic management modalities.
|
 |
|
|
 |
|
In order to show our appreciation to our loyal members who have contributed to diversifying the content of WeBSurg, we are excited to run a WeBSurg special HALL OF FAME.
Videos received from contributors are constantly evaluated during a given time period, which will end in July 2017.
Specific criteria, including image quality (High-Definition standards), scientific and educational relevance, number of views, will be evaluated. The contributors who win the challenge will be offered a special insert in the WeBSurg monthly Newsletter, covering their achievements and expertise in a given field of minimal access surgery. Stay tuned!
Join the HALL OF FAME now and send us your best educational videos! Instructions for video submissions are available here:
|
|
|
 |
VISIT US at the
FOLLOWING CONFERENCES:
The IRCAD-EITS and WeBSurg will be present as an exhibitor hosted by Karl Storz at the forthcoming events:
June 14-17, 2017
EAES 2017 Annual Congress, Frankfurt, Germany
October 22-26, 2017
American College of Surgeons (ACS) Annual Meeting, San Diego, CA, USA
|
|
OTHER CONFERENCES:
June 9-10, 2017
4th International Winners Meeting, Rome, Italy
October 18-21, 2017
26th Annual ESGE Congress, Antalya, Turkey
|
April 27th, 2017
A Live Thyroidectomy Streaming Event, Pisa, Italy
June 15th, 2017
25th international EAES congress, Frankfurt, Germany
|
|
|
 |
STAY TUNED to WEBSURG to discover
our MAY FOCUS
on Laparoscopic Pancreatic Surgery
|
|
Advertising
|
Advertising
|
Copyright © IRCAD ® 2011-2017 all rights reserved
If you want to unsubscribe from this newsletter, please
click here
.
|
